Data / Drug companies / Paclitaxel
Paclitaxel: 20 companies and 41 products in the FDA NDC directory
Paclitaxel is listed in the FDA National Drug Code Directory by 20 companies, with 41 products in commercial distribution. 38 of the products (92.7%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are injection, solution; injection, powder, lyophilized, for suspension; injection, solution, concentrate, and the newest product started marketing on April 1, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 20
- Products
- 41
- Generic (ANDA) products
- 38 (92.7%)
- Application numbers
- 13
- Routes
- Intravenous
- Brand names
- Abraxane
- openFDA record search
- api.fda.gov
Companies that list paclitaxel
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Teva Parenteral Medicines, Inc. | 7 | injection, solution, concentrate | Generic drugs (ANDA) | July 7, 2020 |
| Alembic Pharmaceuticals Inc. | 3 | injection | Generic drugs (ANDA) | October 20, 2022 |
| Alembic Pharmaceuticals Limited | 3 | injection | Generic drugs (ANDA) | October 20, 2022 |
| BluePoint Laboratories | 3 | injection; injection, solution | Generic drugs (ANDA) | April 1, 2026 |
| Gland Pharma Limited | 3 | injection, solution | Generic drugs (ANDA) | September 30, 2016 |
| Heritage Pharmaceuticals Inc. D/B/A Avet Pharmaceuticals Inc. | 3 | injection, solution | Generic drugs (ANDA) | August 31, 2023 |
| Natco Pharma USA LLC | 3 | injection, solution | Generic drugs (ANDA) | November 7, 2024 |
| Novadoz Pharmaceuticals LLC | 3 | injection, solution | Generic drugs (ANDA) | August 26, 2020 |
| Hospira, Inc. | 2 | injection, solution | Generic drugs (ANDA) | April 8, 2025 |
| Abraxis BioScience, LLC | 1 | injection, powder, lyophilized, for suspension | New drug applications (NDA) | February 10, 2005 |
| American Regent, Inc. | 1 | injection, powder, lyophilized, for suspension | New drug applications (NDA) | May 2, 2023 |
| Bryant Ranch Prepack | 1 | injection, solution | Generic drugs (ANDA) | August 26, 2020 |
| Fresenius Kabi USA, LLC | 1 | injection, solution | Generic drugs (ANDA) | March 20, 2009 |
| Meitheal Pharmaceuticals Inc. | 1 | injection, powder, lyophilized, for suspension | Generic drugs (ANDA) | May 15, 2025 |
| Mylan Institutional LLC | 1 | injection, powder, lyophilized, for suspension | Generic drugs (ANDA) | October 9, 2025 |
| NorthStar Rx LLC | 1 | injection, solution | Generic drugs (ANDA) | January 25, 2021 |
| NorthStar RxLLC | 1 | injection, powder, lyophilized, for suspension | Generic drugs (ANDA) | September 10, 2025 |
| Sagent Pharmaceuticals | 1 | injection, solution | Generic drugs (ANDA) | February 1, 2024 |
| Sandoz Inc | 1 | injection, powder, lyophilized, for suspension | Generic drugs (ANDA) | October 8, 2024 |
| Teva Pharmaceuticals, Inc. | 1 | injection, powder, lyophilized, for suspension | New drug applications (NDA) | July 2, 2024 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Injection, solution | 19 | 46.3% |
| Injection, powder, lyophilized, for suspension | 8 | 19.5% |
| Injection, solution, concentrate | 7 | 17.1% |
| Injection | 7 | 17.1% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 38 | 92.7% |
| New drug applications (NDA) | 3 | 7.3% |
Pharmacologic classes
| Class | Products |
|---|---|
| Microtubule Inhibitor | 41 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.